Panbela Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Panbela Therapeutics

05/05/2023 21:12

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted
loss of 65 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 54 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Panbela Therapeutics Inc's reported EPS for the quarter
was a
loss of 65 cents​.
    * The mean earnings estimate of analysts had risen by
about 28.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Panbela Therapeutics Inc shares had risen by 1.8% this
quarter and lost 84.7% so far this year.
    * The company reported a quarterly loss of $5.11 million.
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
5 at 08:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.54          -0.65          Missed
 Dec. 31 2022      -3.70          -5.68          Missed
 Sep. 30 2022      -8.80          -8.40          Beat
 Jun. 30 2022      -10.13         -60.40         Missed